瘤内部异质性:恶性瘤出现和演变的模型
1Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Vavilovskii zhurnal genetiki i selektsii
|January 12, 2024
概括
瘤像生态系统一样进化,由遗传变化和环境因素驱动. 了解癌症演变是开发个性化疗法和改善患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 进化生物学 进化生物学
- 基因组学就是基因组学.
背景情况:
- 癌症是一种复杂的疾病,由遗传改变驱动,导致无法控制的细胞生长.
- 瘤进化是由遗传突变,表观遗传变化,瘤微环境和治疗决定的.
- 了解瘤异质性和进化动态对于有效的癌症治疗至关重要.
研究的目的:
- 描述目前研究癌症进化动态的方法.
- 解释瘤进化和发生的理论.
- 突出进化见解对于个性化癌症治疗的重要性.
主要方法:
- 基因组分析技术,包括下一代测序和光 in situ 杂交.
- 单细胞测序用于剖析内异质性和克隆进化.
- 用于模拟和分析癌症演变的计算模型和算法.
主要成果:
- 癌症的进化受微观进化过程的影响.
- 瘤异质性对治疗疗效提出了挑战.
- 确定关键的遗传和表观遗传驱动因素有助于开发有针对性的治疗方法.
结论:
- 了解癌症的进化复杂性对于个性化医学至关重要.
- 研究瘤的进化动态可以带来尽量减少复发的策略.
- 整合实验和计算方法提供了对癌症演变的全面见解.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


